Management of Chronic Phase Chronic Myeloid Leukemia with Resistance to Multiple TKIs
English
Recorded Courses
hosted by National Comprehensive Cancer Network (NCCN)
hosted by National Comprehensive Cancer Network (NCCN)
attend it anywhere online
category
Medicine, Healthcare Management, Nursing
Nurse Practitioners, Oncology
price
Free
Management of Chronic Phase Chronic Myeloid Leukemia with Resistance to Multiple TKIs is organized by National Comprehensive Cancer Network (NCCN) and will be held from Dec 15, 2022 - Dec 15, 2023.,,Description:,In the majority of patients responding to TKI therapy, chronic myeloid leukemia (CML) is now managed like a chronic disease. However, it poses significant challenges to the clinicians in terms of selection of alternate TKI therapy in patients with inadequate initial response to initial TKI therapy. Informing clinicians about the recent FDA approvals would assist in the incorporation of new treatment options into their routine clinical practice to improve patient outcomes.,,Learning Objectives:,Following this program, participants should be able to:,• Identify the clinical challenges associated with the management of chronic phase chronic myeloid leukemia (CP-CML) resistant to first-line TKI therapy.,• Describe the data from clinical trials supporting the use of ponatinib and asciminib for the management of patients with CP-CML.,• Develop an individualized treatment plan integrating novel treatment options for CP-CML resistant to ?2 prior TKI therapies.,,Additional details will be posted as soon as information is available.